CERRUTI, Fulvia
 Distribuzione geografica
Continente #
NA - Nord America 2.413
EU - Europa 2.005
AS - Asia 624
AF - Africa 69
OC - Oceania 11
Continente sconosciuto - Info sul continente non disponibili 4
SA - Sud America 2
Totale 5.128
Nazione #
US - Stati Uniti d'America 2.385
IT - Italia 688
CN - Cina 339
IE - Irlanda 237
SE - Svezia 206
FR - Francia 169
FI - Finlandia 140
UA - Ucraina 120
DE - Germania 116
DK - Danimarca 107
SG - Singapore 98
KR - Corea 97
PL - Polonia 68
GB - Regno Unito 66
SN - Senegal 66
VN - Vietnam 47
AT - Austria 36
CA - Canada 28
BE - Belgio 19
IN - India 13
RU - Federazione Russa 13
AU - Australia 9
JP - Giappone 9
NL - Olanda 8
ES - Italia 5
HK - Hong Kong 5
EU - Europa 4
TW - Taiwan 4
IL - Israele 3
CH - Svizzera 2
ID - Indonesia 2
MU - Mauritius 2
NZ - Nuova Zelanda 2
RO - Romania 2
AE - Emirati Arabi Uniti 1
BO - Bolivia 1
BR - Brasile 1
CZ - Repubblica Ceca 1
GR - Grecia 1
IR - Iran 1
KE - Kenya 1
LA - Repubblica Popolare Democratica del Laos 1
PH - Filippine 1
RS - Serbia 1
SA - Arabia Saudita 1
TH - Thailandia 1
TR - Turchia 1
Totale 5.128
Città #
Chandler 337
Beijing 250
Dublin 237
Fairfield 187
Torino 129
Ann Arbor 128
Houston 124
Villeurbanne 109
Ashburn 102
Nyköping 101
Dearborn 97
Medford 85
Jacksonville 81
Wilmington 78
Woodbridge 76
Princeton 71
Warsaw 66
Singapore 60
Pisa 52
Seattle 47
New York 46
Vienna 34
Cambridge 33
Milan 32
Rome 26
Boston 25
Dong Ket 23
Toronto 18
Los Angeles 17
San Diego 16
Brussels 15
Fremont 14
Nanjing 14
Redwood City 13
Norwalk 12
Boardman 11
Falls Church 10
Naples 10
Hefei 9
Mountain View 9
San Francisco 8
Shanghai 8
Bari 7
Santa Clara 7
Turin 7
Bologna 6
Kunming 6
San Mateo 6
Buffalo 5
Melbourne 5
Pavia 5
Philadelphia 5
Trieste 5
Verona 5
Hebei 4
Heidelberg 4
Helsinki 4
Hong Kong 4
Mauguio 4
Munich 4
Nanchang 4
Napoli 4
Natick 4
Ottawa 4
Parma 4
Trofarello 4
Acerra 3
Brescia 3
Capua 3
Chongqing 3
Detroit 3
Florence 3
Hangzhou 3
Jinan 3
Lucca 3
Lyons 3
Mondolfo 3
Monrovia 3
Nuremberg 3
Palermo 3
Saint Petersburg 3
Silver Spring 3
Southend 3
Almora 2
Amsterdam 2
Angers 2
Anghiari 2
Aurora 2
Bergamo 2
Bresso 2
Brighton 2
Caserta 2
Chengdu 2
Como 2
Corato 2
Costa Mesa 2
Dallas 2
Dongguan 2
East Lansing 2
Essen 2
Totale 3.022
Nome #
Studio dei proteasomi come potenziali target molecolari di nuove terapie contro il Mesotelioma Pleurico Maligno 224
Attività ed espressione dell'enzima 3-beta-idrossisteroide deidrogenasi in testicoli sani e criptorchidi di suino 208
Comparative study of the biochemical properties of proteasomes in domestic animals 193
Identificazione dei meccanismi molecolari responsabili della sensibilità del mieloma multiplo all’azione pro-apoptotica degli inibitori del proteasoma 176
Low proviral Small Ruminant Lentivirus load as biomarker of natural restriction in goats 167
The amyloidogenic light chain is a stressor that sensitizes plasma cells to proteasome inhibitor toxicity 150
A Quantitative Method to Monitor the Efficacy of Inhibitors Against the Chymotrypsin-Like Activity of the Proteasome in Tobacco Leaf Protoplasts 141
PA28ab Reduces Size and Increases Hydrophilicity of 20S Immunoproteasome Peptide Products 136
MHC class I-related antigen-processing machinery component defects in feline mammary carcinoma. 121
Enhanced rate of degradation of basic proteins by 26S immunoproteasomes. 119
Alterations of the MCH class-I antigen presentation pathway in feline injection-site sarcoma (FISS) 115
Studio della struttura e delle funzioni del PA28 attivatore del proteosoma 111
Proteasome stress sensitizes malignant pleural mesothelioma cells to bortezomib-induced apoptosis 109
Immunological parameters in goats experimentaly infected with SRLV genotype E, strain Roccaverano. 109
Proteasomes are not a target for doxorubicin in feline injection-site sarcoma 108
Espressione immunoistochimica e biochimica dell'osteopontina in testicoli sani e criptorchidi di suino 107
Espressione dell'osteopontina in testicoli sani e criptorchidi di suino:risultati preliminari 102
The proteasome load versus capacity balance determines apoptotic sensitivity of multiple myeloma cells to proteasome inhibition 98
A preliminary study on glycosaminoglycans (GAGs) in central nervous system (CNS) dog tumours 88
I glicosaminoglicani nei tumori cerebrali di cane: studio preliminare 88
Enhanced expression of γ-interferon induced antigen-processing machinery components in a spontaneously occurring cancer 88
Proteasome stress sensitizes malignant pleural mesothelioma cells to bortezomib-induced apoptosis 86
Enhanced expression of gamma-interferon induced antigen processing machinery components in feline-injection site sarcoma 83
Proteasome stress sensitizes malignant pleural mesothelioma cells to Bortezomib-induced apoptosis. 83
3 Beta hydroxysteroid dehydrogenase activity and cryptorchidism 82
Parametri immunologici in capre sperimentalmente infettate con Lentivirus dei Piccoli Ruminanti, genotipo E, stipite Roccaverano 80
Correlation between proteasomes activity, clinical behaviour and histopathological grading in feline and canine malignantspontaneous tumours 73
Studio strutturale e funzionale dell'attivatore dei proteasomi PA28 69
Analisi dell’attività proteasomale come marker per lo studio delle neoplasie 67
Impaired Proteasomal Capacity and ER Stress as Therapeutic Targets Against Multiple Myeloma 65
Progressively impaired proteosomal capacity limits plasma cell lifespan 61
Proteasomes are not a target of doxorubicin in feline-injection site sarcoma 61
Assessing proteostasis and proteasome stress in light chain amyloidosis 61
Iron causes lipid oxidation and inhibits proteasome function in multiple myeloma cells: A proof of concept for novel combination therapies 59
Proteasome decrease during plasma cell differentiation in vivo enables to blunt Ab responses with proteasome inhibitors 58
Progressively impaired proteosomal capacity limits plasma cell lifespan 58
Investigating vulnerability to proteasome inhibition in primary light chain amyloidosis 58
Proteasome levels and activities increase in canine mammary tumors 56
The Proteasomes as complex integrators of stress signals and death responses in canine osteosarcoma: their role as potential molecular targets of new anti-cancer therapies 53
Dampening Ab responses using proteasome inhibitors following in vivo B cell activation 53
Ruolo dei proteosomi nelle risposte immunitarie cellulo-mediate, nei processi di differenziazione dei linfociti B e nella patogenesi della Sclerosi Laterale Amiotrofica 52
Bases of sensitivity of light chain amyloidosis to proteasome inhibitors: assessing proteostasis and proteasome stress 52
Pivotal Advance: Protein synthesis modulates responsiveness of differentiating and malignant plasma cells to proteasome inhibitors 52
Increase in Proteasome levels and activities in Feline Injection-Site Sarcomas 52
Effect of the load versus capacity unbalance on the sensitivity of malignant pleural mesothelioma cells to proteasome inhibitors 52
The plant cell wall is altered by inhibition of polyamine biosynthesis 51
Identification of potential new MHC-I epitopes through in vitro proteasomal degradation of antigenic proteins 51
Comparative study of proteasomal enzymatic activities in farm animals to better understand biochemical mechanisms of antigen processing 51
Role of the apelinergic pathway in colon adenocarcinoma-induced muscle wasting 51
Immunohistochemical study of STAT3 expression in feline injection-site fibrosarcomas 49
Doxorubicin treatment does not affect enhanced immunoproteasome expression and activities in feline-injection site sarcoma 48
In vitro degradation of survivin with 26S proteasome to identify potential new MHC-I antigenic peptides 48
Imbalance between synthetic load and proteasomal capacity as the target of proteasome inhibitors in multiple myeloma 47
The role of ERAD in plant cells: a preliminary biochemical characterization of plant proteasomes 45
PA28αβ Reduces Size and Increases Hydrophilicity of 20S Immunoproteasome Peptide Products 44
BIOCHEMICAL CHARACTERIZATION OF 26S PROTEASOMES IN FARM ANIMALS TO IMPROVE KNOWLEDGE ABOUT ANTIGEN PROCESSING 44
Electron microscopy and functional studies reveal cellular stress in amyloidogenic plasma cells 43
Electron microscopy and functional studies reveal cellular stress in amyloidogenic plasma cells 42
The load versus capacity unbalance sensitizes Malignant Pleural Mesothelioma cells to proteasome inhibitors 40
New methods to improve in vitro proteasomal degradation of the universal tumor antigene Survivin and to identify potential new MHC-I epitopes 39
Progressively impaired proteasomal capacity during terminal plasma cell differentiation 39
In vitro proteasomal degradation of antigenic proteins to identify potential new MHC-I epitopes 38
Proteasome stress causes apoptotic sensitivity of multiple myeloma cells to proteasome inhibition 37
Impaired proteasomal capacity as the target of proteasome inhibitors in multiple myeloma 36
Studio strutturale e funzionale dei proteasomi 20S e 26S nelle cellule vegetali con particolare riferimento al lororuolo nel processo di Degradazione Associata all’ER (ERAD) 36
The Load vs. Capacity model: a quantitative approach to understand the exquisite sensitivity of plasma cells to proteasome inhibitors 34
Inherent cellular stress and exquisite proteasome sensitivity in amyloidogenic plasma cells 34
PA28γ–20S proteasome is a proteolytic complex committed to degrade unfolded proteins 32
Imbalance between synthetic load and proteasomal capacity sensitizes normal and malignant plasma cells to proteasome inhibitors 27
PA28αβ-induced modifications in the patterns of peptides produced by proteasomes from full length protein substrates 27
Imbalance between synthetic load and proteasomal capacity sensitizes normal and malignant plasma cells to proteasome inhibitors 20
Detection and biochemical characterization of circulating proteasomes in dog plasma 9
Totale 5.346
Categoria #
all - tutte 15.318
article - articoli 0
book - libri 0
conference - conferenze 7.546
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 22.864


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020834 0 0 102 142 46 114 114 47 72 85 66 46
2020/2021594 78 29 35 30 55 24 64 25 77 71 30 76
2021/2022663 40 25 23 43 23 29 62 25 27 37 151 178
2022/20231.035 128 87 37 95 87 249 104 50 102 26 47 23
2023/2024439 62 91 15 30 24 66 13 14 4 24 30 66
2024/202564 17 47 0 0 0 0 0 0 0 0 0 0
Totale 5.346